Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer

BACKGROUND: Colorectal cancer is one of the most frequent and lethal cancers. The aim of this study was to analyze the costs relating to treatment of colorectal cancer between Xelox and Folfox-4 at a regional level according to the clinical experience at an Italian hospital in Lombardy. METHODS: A c...

Descripción completa

Detalles Bibliográficos
Autores principales: Aitini, Enrico, Rossi, Anna, Morselli, Patrizia, Vivorio, Beatrice, Bruschi, Alessandra, Bottura, Chiara, Colombo, Giorgio L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324994/
https://www.ncbi.nlm.nih.gov/pubmed/22500126
http://dx.doi.org/10.2147/CMAR.S29267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324994/
https://www.ncbi.nlm.nih.gov/pubmed/22500126
http://dx.doi.org/10.2147/CMAR.S29267

Ejemplares similares